Myriad Genetics, Inc. (MYGN)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$4.65
-3.93%
Mkt Cap $446.97M
Analyst Ratings
Buy
1
Hold
5
Sell
0
Price Target (17 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
+29.2%
Consensus $6.00 vs current $4.65